Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression

Che-Chung Lin, I‐Ying Kuo, Liting Wu, Wen‐Hui Kuan, Shengyou Liao, Jayu Jen, You-En Yang, Chengwei Tang, Yi‐Rong Chen, Yi‐Ching Wang

Theranostics · 2020 · 50 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

These findings highlight the mechanism by which dysregulation of Kras/YY1/ZNF322/Shh transcriptional axis enhances neo-angiogenesis and cancer progression in lung cancer. Therapeutic strategies that target Kras/YY1/ZNF322A/Shh signaling axis may provide new insight on targeted therapy for lung cancer patients.

References

35